By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



275 Grove Street
Suite 2-400
Newton  Massachusetts  02466  U.S.A.
Phone: 617-965-2521 Fax: 617-963-7389


Company News
Baxter International, Inc. (BAX) Snags Orphan Drug-Focused Biopharma, AesRx For Undisclosed Amount 7/9/2014 7:47:55 AM
AesRx Presents Phase 1/2a Trial Data Of Anti-Sickling Agent Aes-103 At American Society of Hematology 12/9/2013 10:21:48 AM
AesRx Anti-Sickling Drug Aes-103 Begins Phase 2 Trial 9/3/2013 10:33:00 AM
AesRx to Present Phase 1 Data on Anti-Sickling Agent Aes-103 at American Society of Hematology 11/27/2012 12:27:11 PM
AesRx Anti-Sickling Drug Aes-103 Enters Phase 1/2a Clinical Trial at National Institutes of Health (NIH) 5/14/2012 11:00:50 AM
AesRx Begins Clinical Trial of AES-103 for Sickle Cell Disease 12/6/2011 9:19:33 AM
AesRx Announces Collaboration With National Institutes of Health (NIH) to Develop Aes-103 for Sickle Cell Disease 11/17/2010 2:24:13 PM
Professor Henry Louis Gates, Jr., Joins AesRx Strategic Advisory Board 6/1/2010 2:25:53 PM
AesRx Appoints Jordan, CMO of Sickle Cell Disease Association of America, to Clinical Advisory Board 2/25/2010 11:33:24 AM
Former Idera Pharmaceuticals, Inc. (IDRA) CEO at Helm of AesRx, New Startup With Sickle Cell Drug 1/5/2010 7:25:35 AM